Related references
Note: Only part of the references are listed.Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial
Lili Ren et al.
CLINICAL INFECTIOUS DISEASES (2021)
Is COVID-19 receiving ADE from other coronaviruses?
Jason A. Tetro
MICROBES AND INFECTION (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Li Guo et al.
CLINICAL INFECTIOUS DISEASES (2020)
COVID-19 diagnosis and management: a comprehensive review
Giuseppe Pascarella et al.
JOURNAL OF INTERNAL MEDICINE (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Abishek Chandrashekar et al.
SCIENCE (2020)
SARS-CoV-2 Infection Leads to Neurological Dysfunction
Arpan Acharya et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients
Slim Fourati et al.
INTENSIVE CARE MEDICINE (2020)
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
Ren Yang et al.
EBIOMEDICINE (2020)
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Samira Fafi-Kremer et al.
EBIOMEDICINE (2020)
Epidemiology and clinical features of COVID-19: A review of current literature
Juan A. Siordia
JOURNAL OF CLINICAL VIROLOGY (2020)
Coronaviruses pandemics: Can neutralizing antibodies help?
Phuoc-Bao-Viet Tong et al.
LIFE SCIENCES (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Kinetics of viral load and antibody response in relation to COVID-19 severity
Yanqun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
Fan Wu et al.
JAMA INTERNAL MEDICINE (2020)
Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity
Kathleen M. McAndrews et al.
JCI INSIGHT (2020)
Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients
Linghua Li et al.
VIROLOGY (2020)
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
Hongyan Hou et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression
Xia Yu et al.
CRITICAL CARE (2020)
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
Huan Han et al.
EMERGING MICROBES & INFECTIONS (2020)
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
Daniel C. Payne et al.
EMERGING INFECTIOUS DISEASES (2016)
Disappearance of antibodies to SARS-associated coronavirus after recovery
Wu-Chun Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry
R Broer et al.
JOURNAL OF VIROLOGY (2006)
Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance
HY Mo et al.
RESPIROLOGY (2006)
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection
D Lavillette et al.
JOURNAL OF VIROLOGY (2005)
Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection
YC Nie et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Share Paper
